当前位置:
X-MOL 学术
›
Arthritis Rheumatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Weight Loss After Receiving Anti-Obesity Medications and Gout Among Individuals With Overweight and Obese: A Population-Based Cohort Study
Arthritis & Rheumatology ( IF 11.4 ) Pub Date : 2024-09-19 , DOI: 10.1002/art.42996 Jie Wei, Yilun Wang, Nicola Dalbeth, Junqing Xie, Jing Wu, Chao Zeng, Guanghua Lei, Yuqing Zhang
Arthritis & Rheumatology ( IF 11.4 ) Pub Date : 2024-09-19 , DOI: 10.1002/art.42996 Jie Wei, Yilun Wang, Nicola Dalbeth, Junqing Xie, Jing Wu, Chao Zeng, Guanghua Lei, Yuqing Zhang
Weight loss is conditionally recommended for gout management; however, its impact on incident gout and recurrent gout flares among individuals who were overweight and obese remains unknown. We investigate the relationship between weight loss rate following treatment with anti-obesity medications and the risk of incident gout and recurrent gout flares among individuals who were overweight or obese.
中文翻译:
超重和肥胖个体接受抗肥胖药物和痛风后体重减轻:一项基于人群的队列研究
有条件地建议减轻体重用于痛风管理;然而,它对超重和肥胖个体的痛风新发和复发性痛风发作的影响仍然未知。我们调查了抗肥胖药物治疗后体重减轻率与超重或肥胖个体发生痛风和复发性痛风发作风险之间的关系。
更新日期:2024-09-19
中文翻译:
超重和肥胖个体接受抗肥胖药物和痛风后体重减轻:一项基于人群的队列研究
有条件地建议减轻体重用于痛风管理;然而,它对超重和肥胖个体的痛风新发和复发性痛风发作的影响仍然未知。我们调查了抗肥胖药物治疗后体重减轻率与超重或肥胖个体发生痛风和复发性痛风发作风险之间的关系。